Literature DB >> 24910016

A study on the association between infectious burden and Alzheimer's disease.

X-L Bu1, X-Q Yao1, S-S Jiao1, F Zeng1, Y-H Liu1, Y Xiang1, C-R Liang1, Q-H Wang1, X Wang1, H-Y Cao1, X Yi1, B Deng1, C-H Liu1, J Xu1, L-L Zhang1, C-Y Gao1, Z-Q Xu1, M Zhang1, L Wang1, X-L Tan2, X Xu3, H-D Zhou1, Y-J Wang1.   

Abstract

BACKGROUND AND
PURPOSE: Previous studies suggested that the overall burden of prior infections contributes to cardiovascular diseases and stroke. In the present study, the association between infectious burden (IB) and Alzheimer's disease (AD) was examined.
METHODS: Antibody titers to common infectious pathogens including cytomegalovirus (CMV), herpes simplex virus type 1 (HSV-1), Borrelia burgdorferi, Chlamydophila pneumoniae and Helicobacter pylori were measured by enzyme-linked immunosorbent assay in 128 AD patients and 135 healthy controls. IB was defined as a composite serological measure of exposure to these common pathogens.
RESULTS: Seropositivities toward zero-two, three and four-five of these pathogens were found in 44%, 40% and 16% of healthy controls but in 20%, 44% and 36% of AD patients, respectively. IB, bacterial burden and viral burden were independently associated with AD after adjusting for age, gender, education, APOE genotype and various comorbidities. Mini-Mental State Examination scores were negatively correlated with IB in all cases. Serum beta-amyloid protein (Aβ) levels (i.e. Aβ40, Aβ42 and total Aβ) and inflammatory cytokines (i.e. interferon-γ, tumor necrosis factor α, interleukin-1β and interleukin-6) in individuals exposed to four-five infectious pathogens were significantly higher than those exposed to zero-two or three pathogens.
CONCLUSIONS: IB consisting of CMV, HSV-1, B. burgdorferi, C. pneumoniae and H. pylori is associated with AD. This study supports the role of infection/inflammation in the etiopathogenesis of AD.
© 2014 The Author(s) European Journal of Neurology © 2014 EAN.

Entities:  

Keywords:  Alzheimer's disease; beta-amyloid; case−control study; infections; risk factors

Mesh:

Substances:

Year:  2014        PMID: 24910016     DOI: 10.1111/ene.12477

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  78 in total

Review 1.  The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ.

Authors:  Cong Zheng; Xin-Wen Zhou; Jian-Zhi Wang
Journal:  Transl Neurodegener       Date:  2016-04-05       Impact factor: 8.014

2.  Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer?

Authors:  Mahmoud Mahami-Oskouei; Faezeh Hamidi; Mahnaz Talebi; Mehdi Farhoudi; Ali Akbar Taheraghdam; Tohid Kazemi; Homayoun Sadeghi-Bazargani; Esmaeil Fallah
Journal:  Parasitol Res       Date:  2016-04-23       Impact factor: 2.289

3.  FTY720 Attenuates Infection-Induced Enhancement of Aβ Accumulation in APP/PS1 Mice by Modulating Astrocytic Activation.

Authors:  Róisín M McManus; Orla M Finucane; Mieszko M Wilk; Kingston H G Mills; Marina A Lynch
Journal:  J Neuroimmune Pharmacol       Date:  2017-06-15       Impact factor: 4.147

Review 4.  Interactions between the microbiota, immune and nervous systems in health and disease.

Authors:  Thomas C Fung; Christine A Olson; Elaine Y Hsiao
Journal:  Nat Neurosci       Date:  2017-01-16       Impact factor: 24.884

Review 5.  Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.

Authors:  Namhee Kim; Misun Yun; Young Joon Oh; Hak-Jong Choi
Journal:  J Microbiol       Date:  2018-02-28       Impact factor: 3.422

Review 6.  Known unknowns: how might the persistent herpesvirome shape immunity and aging?

Authors:  Janko Nikolich-Zugich; Felicia Goodrum; Kenneth Knox; Megan J Smithey
Journal:  Curr Opin Immunol       Date:  2017-08-04       Impact factor: 7.486

7.  Association of Polygenic Risk Score with Age at Onset and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in a Chinese Cohort.

Authors:  Wei-Wei Li; Zhen Wang; Dong-Yu Fan; Ying-Ying Shen; Dong-Wan Chen; Hui-Yun Li; Ling Li; Heng Yang; Yu-Hui Liu; Xian-Le Bu; Wang-Sheng Jin; Fan Zeng; Zhi-Qiang Xu; Jin-Tai Yu; Li-Yong Chen; Yan-Jiang Wang
Journal:  Neurosci Bull       Date:  2020-02-18       Impact factor: 5.203

8.  Associations Between Hepatic Functions and Plasma Amyloid-Beta Levels-Implications for the Capacity of Liver in Peripheral Amyloid-Beta Clearance.

Authors:  Ye-Ran Wang; Qing-Hua Wang; Tao Zhang; Yu-Hui Liu; Xiu-Qing Yao; Fan Zeng; Jing Li; Fa-Yin Zhou; Lin Wang; Jia-Chuan Yan; Hua-Dong Zhou; Yan-Jiang Wang
Journal:  Mol Neurobiol       Date:  2016-03-09       Impact factor: 5.590

Review 9.  Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis.

Authors:  Paolo Riccio; Rocco Rossano
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

10.  Serum Amyloid-Beta Levels are Increased in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Xian-Le Bu; Guo-Qiang Cao; Lin-Lin Shen; Yang Xiang; Shu-Sheng Jiao; Yu-Hui Liu; Chi Zhu; Fan Zeng; Qing-Hua Wang; Ye-Ran Wang; Yong He; Hua-Dong Zhou; Yan-Jiang Wang
Journal:  Neurotox Res       Date:  2015-08-05       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.